An evaluation of tedizolid for the treatment of MRSA infections. (Record no. 28821336)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01292 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517235454.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201810s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1744-7666 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1080/14656566.2018.1519021 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hall, Ronald G |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20181001 |
245 00 - TITLE STATEMENT | |
Title | An evaluation of tedizolid for the treatment of MRSA infections. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Expert opinion on pharmacotherapy |
Date of publication, distribution, etc. | Sep 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1489-1494 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Bacterial Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Linezolid |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Methicillin-Resistant Staphylococcus aureus |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxazolidinones |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Soft Tissue Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Staphylococcal Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tetrazoles |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Smith, Winter J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Putnam, William C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pass, Steven E |
773 0# - HOST ITEM ENTRY | |
Title | Expert opinion on pharmacotherapy |
Related parts | vol. 19 |
-- | no. 13 |
-- | p. 1489-1494 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1080/14656566.2018.1519021">https://doi.org/10.1080/14656566.2018.1519021</a> |
Public note | Available from publisher's website |
No items available.